BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 2003;17:887-93. [PMID: 12656691 DOI: 10.1046/j.1365-2036.2003.01485.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Chebane L, Bagheri H, Hillaire-buys D, Géniaux H, Yahioui N, Laroche M, Cottin J, Spreux A, Mosquet B, Pecriaux C, Bellet F, Lambert A, Montastruc J. Pancréatites d’origine médicamenteuse. Revue des notifications spontanées en France. La Revue de Médecine Interne 2015;36:573-8. [DOI: 10.1016/j.revmed.2015.04.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bertilsson S, Kalaitzakis E. Acute Pancreatitis and Use of Pancreatitis-Associated Drugs: A 10-Year Population-Based Cohort Study. Pancreas 2015;44:1096-104. [PMID: 26335010 DOI: 10.1097/MPA.0000000000000406] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
3 Mahrous DM, Abdel Hakeem GL, Abdel Aziz RAS, Higazi AM. Assessment of Subclinical Pancreatitis in Epileptic Children With Different Treatment Modalities. Child Neurol Open 2016;3:2329048X16658364. [PMID: 28503610 DOI: 10.1177/2329048X16658364] [Reference Citation Analysis]
4 Koskensalo V, Aronen P, Färkkilä M, Kylänpää L, Lindström O, Rainio M, Udd M, Jokelainen K, Tenca A. Use of thiopurines is not a risk factor for post-ERC pancreatitis in patients with primary sclerosing cholangitis. Dig Liver Dis 2021;53:1020-7. [PMID: 34116970 DOI: 10.1016/j.dld.2021.05.009] [Reference Citation Analysis]
5 Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143-155. [PMID: 20227028 DOI: 10.1016/j.bpg.2010.02.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
6 Yamamoto M, Wei L, Otani M, Harada M, Otsuki M. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats. Regulatory Peptides 2012;178:80-5. [DOI: 10.1016/j.regpep.2012.06.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 2006;29:1123-1132. [PMID: 17147459 DOI: 10.2165/00002018-200629120-00004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
8 Daher Ede F, Brunetta DM, de Silva Júnior GB, Puster RA, Patrocínio RM. Pancreatic involvement in fatal human leptospirosis: clinical and histopathological features. Rev Inst Med Trop Sao Paulo 2003;45:307-13. [PMID: 14762628 DOI: 10.1590/s0036-46652003000600002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
9 Nørgaard M, Ratanajamit C, Jacobsen J, Skriver MV, Pedersen L, Sørensen HT. Metronidazole and risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2005;21:415-20. [PMID: 15709992 DOI: 10.1111/j.1365-2036.2005.02344.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
10 Mardini HE. Azathioprine-induced pancreatitis in Crohn's disease: a smoking gun or guilt by association. Aliment Pharmacol Ther 2005;21:195-195. [DOI: 10.1111/j.1365-2036.2005.02315.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
11 Silva MA, Key S, Han E, Malloy MJ. Acute Pancreatitis Associated With Antipsychotic Medication: Evaluation of Clinical Features, Treatment, and Polypharmacy in a Series of Cases. Journal of Clinical Psychopharmacology 2016;36:169-72. [DOI: 10.1097/jcp.0000000000000459] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Ockenga J, Kreutz R, Garbe E. Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases. Aliment Pharmacol Ther 2013;38:825-34. [PMID: 23957710 DOI: 10.1111/apt.12461] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
13 Song QL, Guan Y. A case of acute pancreatitis induced by voriconazole during treatment of cryptococcal meningitis. Br J Clin Pharmacol 2021. [PMID: 34214221 DOI: 10.1111/bcp.14957] [Reference Citation Analysis]
14 Youssef I, Saeed N, El Abdallah M, Huevelhorst K, Zakharia K. Metronidazole-Induced Pancreatitis: Is There Underrecognition? A Case Report and Systematic Review of the Literature. Case Rep Gastrointest Med 2019;2019:4840539. [PMID: 31281684 DOI: 10.1155/2019/4840539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Abraham A, Raghavan P, Patel R, Rajan D, Singh J, Mustacchia P. Acute pancreatitis induced by methimazole therapy. Case Rep Gastroenterol 2012;6:223-31. [PMID: 22679409 DOI: 10.1159/000338652] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
16 Nørgaard M, Jacobsen J, Ratanajamit C, Jepsen P, McLaughlin JK, Pedersen L, Sørensen HT. Valproic acid and risk of acute pancreatitis: a population-based case-control study. Am J Ther 2006;13:113-7. [PMID: 16645426 DOI: 10.1097/00045391-200603000-00005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
17 Rouette J, Yin H, McDonald EG, Barkun A, Azoulay L. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort Study. Drug Saf 2021. [PMID: 34714528 DOI: 10.1007/s40264-021-01128-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yoo JH, Kwon C, Yoo K, Yoon H, Kim WH, Ko KH, Hong SP, Park PW. Effect of Proton Pump Inhibitor in Patients with Acute Pancreatitis - Pilot Study. Korean J Gastroenterol 2012;60:362. [DOI: 10.4166/kjg.2012.60.6.362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kuoppala J, Enlund H, Pulkkinen J, Kastarinen H, Jyrkkä J, Happonen P, Paajanen H. ACE inhibitors and the risk of acute pancreatitis-a population-based case-control study: ACE Inhibitors and Acute Pancreatitis. Pharmacoepidemiol Drug Saf 2017;26:853-7. [DOI: 10.1002/pds.4179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D’incà R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G, Aratari A, Bossa F, Cappello M, Cassinotti A, Chiriatti A, Fiorino G, Formica V, Guidi L, Losco A, Mocciaro F, Onali S, Pastorelli L, Pica R, Principi M, Renna S, Ricci C, Rispo A, Rogai F, Sarmati L, Scaldaferri F, Spina L, Tambasco R, Testa A, Viscido A. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 2017;49:338-58. [DOI: 10.1016/j.dld.2017.01.141] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
21 Inayat F, Virk HU, Yoon DJ, Riaz I. Drug-Induced Pancreatitis: A Rare Manifestation of Doxycycline Administration. N Am J Med Sci 2016;8:117-20. [PMID: 27042611 DOI: 10.4103/1947-2714.174348] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
22 Zhang L, Zhang J, Shea K, Xu L, Tobin G, Knapton A, Sharron S, Rouse R. Autophagy in pancreatic acinar cells in caerulein-treated mice: immunolocalization of related proteins and their potential as markers of pancreatitis. Toxicol Pathol 2014;42:435-57. [PMID: 23640381 DOI: 10.1177/0192623313486967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
23 Pilmis B, Coignard-biehler H, Rouzaud C, Jullien V, Lanternier F, Lortholary O. Acute reversible pancreatitis induced by posaconazole. J Antimicrob Chemother 2017;72:628-30. [DOI: 10.1093/jac/dkw465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Forsmark CE, Baillie J; AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022-2044. [PMID: 17484894 DOI: 10.1053/j.gastro.2007.03.065] [Cited by in Crossref: 450] [Cited by in F6Publishing: 379] [Article Influence: 32.1] [Reference Citation Analysis]
25 Ksiądzyna D. Drug-induced acute pancreatitis related to medications commonly used in gastroenterology. European Journal of Internal Medicine 2011;22:20-5. [DOI: 10.1016/j.ejim.2010.09.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
26 Simons-linares CR, Elkhouly MA, Salazar MJ. Drug-Induced Acute Pancreatitis in Adults: An Update. Pancreas 2019;48:1263-73. [DOI: 10.1097/mpa.0000000000001428] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
27 Thisted H, Jacobsen J, Munk EM, Nørgaard B, Friis S, McLaughlin JK, Sørensen HT, Johnsen SP. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther. 2006;23:185-190. [PMID: 16393296 DOI: 10.1111/j.1365-2036.2006.02728.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
28 Martinelli M, Strisciuglio C, Illiceto MT, Cardile S, Guariso G, Vignola S, Aloi M, D’altilia MR, Alvisi P, Salvatore S, Staiano A, Cucchiara S, Miele E. Natural history of pancreatic involvement in paediatric inflammatory bowel disease. Digestive and Liver Disease 2015;47:384-9. [DOI: 10.1016/j.dld.2015.01.155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
29 Flaig T, Douros A, Bronder E, Klimpel A, Kreutz R, Garbe E. Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System. J Clin Pharm Ther. 2016;41:718-721. [PMID: 27670839 DOI: 10.1111/jcpt.12456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
30 Wei L, Yamamoto M, Harada M, Otsuki M. Treatment with pravastatin attenuates progression of chronic pancreatitis in rat. Lab Invest. 2011;91:872-884. [PMID: 21383674 DOI: 10.1038/labinvest.2011.41] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
31 Moss AC, Peppercorn MA. The risks and the benefits of mesalazine as a treatment for ulcerative colitis. Expert Opinion on Drug Safety 2007;6:99-107. [DOI: 10.1517/14740338.6.2.99] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
32 Poropat G, Archibugi L, Korpela T, Cárdenas-Jaén K, de-Madaria E, Capurso G. Statin use is not associated with an increased risk of acute pancreatitis-A meta-analysis of observational studies. United European Gastroenterol J 2018;6:1206-14. [PMID: 30288283 DOI: 10.1177/2050640618781168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
33 Hermida Ameijeiras J, Tutor Crespo M, Tutor Valcarce J. Lipasa y amilasa total y sus isoenzimas como marcadores de daño pancreático en pacientes tratados con fármacos antiepilépticos. Farmacia Hospitalaria 2007;31:303-6. [DOI: 10.1016/s1130-6343(07)75393-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Giorda CB, Nada E, Tartaglino B, Marafetti L, Gnavi R. A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. Diabetes Obes Metab. 2014;16:1041-1047. [PMID: 24702687 DOI: 10.1111/dom.12297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
35 Tsesmeli NE, Giannoulis KE, Savopoulos CG, Vretou EE, Ekonomou IA, Giannoulis EK. Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis. Eur J Gastroenterol Hepatol. 2007;19:805-806. [PMID: 17700268 DOI: 10.1097/meg.0b013e328133f2fb] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Navabi SJ, Khosravifar M, Navabi SM, Heydari R. Acute pancreatitis induced by Tadalafil: a case report. Clin J Gastroenterol 2020;13:459-64. [PMID: 31797202 DOI: 10.1007/s12328-019-01070-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Foster JR. A review of animal models of nonneoplastic pancreatic diseases. Toxicol Pathol. 2014;42:243-259. [PMID: 24178571 DOI: 10.1177/0192623313508479] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
38 Kuoppala J, Pulkkinen J, Kastarinen H, Kiviniemi V, Jyrkkä J, Enlund H, Happonen P, Paajanen H. Use of statins and the risk of acute pancreatitis: a population-based case-control study: Statins and Acute Pancreatitis. Pharmacoepidemiol Drug Saf 2015;24:1085-92. [DOI: 10.1002/pds.3858] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
39 Liao KF, Cheng KC, Lin CL, Lai SW. Etodolac and the risk of acute pancreatitis. Biomedicine (Taipei). 2017;7:4. [PMID: 28474580 DOI: 10.1051/bmdcn/2017070104] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 7.5] [Reference Citation Analysis]
40 Nørgaard M, Jacobsen J, Gasse C, Pedersen L, Mortensen PB, Sørensen HT. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study. J Clin Psychopharmacol 2007;27:259-62. [PMID: 17502772 DOI: 10.1097/JCP.0b013e318058a9c3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
41 Smithson J, Mitchell PB. Antidepressants. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Elsevier; 2019. pp. 13-26. [DOI: 10.1016/bs.seda.2019.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Sundström A, Blomgren K, Alfredsson L, Wiholm BE. Acid-suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis--results from a Swedish Case-Control Study. Pharmacoepidemiol Drug Saf. 2006;15:141-149. [PMID: 16200654 DOI: 10.1002/pds.1137] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
43 Eland IA, Sundström A, Velo GP, Andersen M, Sturkenboom MCJM, Langman MJS, Stricker BHC, Wiholm B, Eland IA, Sundström A, Velo GP, Andersen M, Sturkenboom MCJM, Langman MJS, Stricker BHC, Wiholm B, For The Edip Study Group Of The Eur. Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP). Scandinavian Journal of Gastroenterology 2009;41:1484-90. [DOI: 10.1080/00365520600761676] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
44 Yao S, Li J, Fan X, Liu Q, Lian J. The effect of selective serotonin re-uptake inhibitors on risk of type II diabetes mellitus and acute pancreatitis: a meta-analysis. Biosci Rep. 2018;38:BSR20180967. [PMID: 30126851 DOI: 10.1042/bsr20180967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H. Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission: A Prospective Analysis of 907 Patients in Two German University Hospitals. Drug Safety 2008;31:789-98. [DOI: 10.2165/00002018-200831090-00007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
46 Patil SA, Moss AC. Balsalazide disodium for the treatment of ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2014;2:177-84. [DOI: 10.1586/17474124.2.2.177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Balani AR, Grendell JH. Drug-Induced Pancreatitis: Incidence, Management and Prevention. Drug Safety 2008;31:823-37. [DOI: 10.2165/00002018-200831100-00002] [Cited by in Crossref: 118] [Cited by in F6Publishing: 93] [Article Influence: 9.1] [Reference Citation Analysis]
48 Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. Curr Gastroenterol Rep. 2012;14:131-138. [PMID: 22314811 DOI: 10.1007/s11894-012-0245-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 8.8] [Reference Citation Analysis]
49 Ljung R, Rück C, Mattsson F, Bexelius TS, Lagergren J, Lindblad M. Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: a Swedish population-based case-control study. J Clin Psychopharmacol 2012;32:336-40. [PMID: 22544014 DOI: 10.1097/JCP.0b013e318253d71a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Manfredi R, Dentale N, Fortunato L, Pavoni M, Calza L, Chiodo F. Pancreotoxicity of Propofol Sedation during Purulent Meningitis : What is the Role for Octreotide? Clin Drug Investig 2004;24:181-3. [PMID: 17516703 DOI: 10.2165/00044011-200424030-00005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Raschi E, Piccinni C, Poluzzi E, Marchesini G, De Ponti F. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. Acta Diabetol. 2013;50:569-577. [PMID: 22008948 DOI: 10.1007/s00592-011-0340-7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
52 Gagnon AL, Lavoie A, Frigon MP, Michaud-Herbst A, Tremblay K. A Drug-Induced Acute Pancreatitis Retrospective Study. Can J Gastroenterol Hepatol 2020;2020:1516493. [PMID: 33204673 DOI: 10.1155/2020/1516493] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Hauben M, Reich L. Drug-induced pancreatitis: lessons in data mining. Br J Clin Pharmacol 2004;58:560-2. [PMID: 15521907 DOI: 10.1111/j.1365-2125.2004.02203.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
54 Hsu FG, Hsieh YW, Sheu MJ, Lin CC, Lin CL, Hsu CY, Lee CY, Chang MY, Chang KH. Tamoxifen use and acute pancreatitis: A population-based cohort study. PLoS One 2017;12:e0173089. [PMID: 28291833 DOI: 10.1371/journal.pone.0173089] [Reference Citation Analysis]
55 Lin HF, Liao KF, Chang CM, Lin CL, Lai SW. Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan. Eur J Clin Pharmacol 2017;73:1615-21. [PMID: 28856398 DOI: 10.1007/s00228-017-2328-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
56 Logan RF, van Staa TP. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2003;52:1530; author reply 1530-1531. [PMID: 12970150 DOI: 10.1136/gut.52.10.1530] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
57 Grendell JH. Editorial: drug-induced acute pancreatitis: uncommon or commonplace? Am J Gastroenterol. 2011;106:2189-2191. [PMID: 22138943 DOI: 10.1038/ajg.2011.307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]